Inventor · disambiguated record
Ana Tari Ashizawa
Also filed as: ASHIZAWA ANA · ASHIZAWA ANA TARI
6 granted patents·2 pending applications·8 citations·filing 2017–2021
73Inventor score
Files withBIO PATH HOLDINGS INC8
Top patents by PatentIndex Score
8 records- 0185US11041153B2P-ethoxy nucleic acids for STAT3 inhibitionBIO PATH HOLDINGS INC·Filed 2018·Granted Jun 22, 2021·4 cites·34 claims
- 0285US10927379B2Combination therapy with liposomal antisense oligonucleotidesBIO PATH HOLDINGS INC·Filed 2017·Granted Feb 23, 2021·4 cites·56 claims
- 0368US12472199B2P-ethoxy nucleic acids for IGF-1R inhibitionBIO PATH HOLDINGS INC·Filed 2021·Granted Nov 18, 2025·0 cites·4 claims
- 0466US12319911B2P-ethoxy nucleic acids for STAT3 inhibitionBIO PATH HOLDINGS INC·Filed 2021·Granted Jun 3, 2025·0 cites·21 claims
- 0566US12012601B2Combination therapy with liposomal antisense oligonucleotidesBIO PATH HOLDINGS INC·Filed 2021·Granted Jun 18, 2024·0 cites·19 claims
- 0657US2020038429A1P-ethoxy nucleic acids for igf-1r inhibitionBIO PATH HOLDINGS INC·Filed 2018·Application pending·0 cites
- 0745US12234457B2P-ethoxy nucleic acids for BCL2 inhibitionBIO PATH HOLDINGS INC·Filed 2018·Granted Feb 25, 2025·0 cites·26 claims
- 0843US2021115451A1P-ethoxy nucleic acids for igf-1r inhibitionBIO PATH HOLDINGS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ana Tari Ashizawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →